SMART
The purpose of this trial is to generate clinical evidence on valve safety and performance of self-expanding (SE) versus balloon-expandable (BE) transcatheter aortic valve replacement (TAVR) in subjects with a small aortic annulus and symptomatic鈥�
- Investigator
- R. David Anderson
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All
Cardiamp CMI
Prospective, multi-center, 2:1 randomized (Treatment : Sham Control), sham-controlled, double-blinded trial to compare treatment using the CardiAMP cell therapy system to sham treatment
Treatment Group:
Subjects treated with aBMC using the CardiAMP鈥�
- Investigator
- R. David Anderson
- Status
- Accepting Candidates
- Ages
- 21 Years - 80 Years
- Sexes
- All